Update shared on22 Sep 2025
Fair value Increased 2.64%The slight upward revision in the price target for People's Insurance Company (Group) of China is primarily driven by a modest increase in consensus revenue growth forecasts, with fair value rising from HK$6.68 to HK$6.85.
What's in the News
- Proposed interim dividend of RMB 0.075 per share for the first half of 2025, payable on 16 January 2026.
- Board meeting scheduled to consider interim results and payment of an interim dividend for the six months ended 30 June 2025.
- AGM approved amendments to the Articles of Association; changes effective upon NFRA approval.
Valuation Changes
Summary of Valuation Changes for People's Insurance Company (Group) of China
- The Consensus Analyst Price Target has risen slightly from HK$6.68 to HK$6.85.
- The Consensus Revenue Growth forecasts for People's Insurance Company (Group) of China has risen slightly from 4.0% per annum to 4.1% per annum.
- The Future P/E for People's Insurance Company (Group) of China remained effectively unchanged, moving only marginally from 7.87x to 8.01x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.